Under construction – not a live service
Sign in
Not yet taking people in BrazilNo phase

Peer-led HIV prevention pill delivery for young people in Brazil

Tests youth peers delivering HIV prevention pills to other people aged 15-24.

Plain-language title generated from the registry record
Registry title: Peer-led Community-based PrEP Delivery Among Youth in Brazil

Key facts

Where
Salvador and São Paulo, BrazilSee the 2 sites

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 15 and 24 years old?

Source: NCT06661356, who can take part

Where in Brazil

  • Federal University of BahiaSalvador, BrazilNo longer taking part
  • University of Sao PauloSão Paulo, BrazilNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University of Alabama at Birmingham
Trial code
NCT06661356
Record updated
13 October 2026
Original description
The goal of this project is to conduct a series of studies to refine, test, and understand experiences with a peer-led community-based intervention in which youth will be integrated into health care teams and trained to deliver HIV pre-exposure prophylaxis (PrEP) to their peers. The study team will conduct a randomized trial to determine if peer delivery of PrEP to youth aged 15-24 in Brazil will increase PrEP uptake, persistence, and adherence compared to standard PrEP care provided in health facilities.Read full original descriptionShow less

Determining the Impact of Peer-led Community-based PrEP Delivery Among Youth in Brazil: A Randomized Controlled Trial

The goal of this project is to conduct a series of studies to refine, test, and understand experiences with a peer-led community-based intervention in which youth will be integrated into health care teams and trained to deliver HIV pre-exposure prophylaxis (PrEP) to their peers. The study team will conduct a randomized trial to determine if peer delivery of PrEP to youth aged 15-24 in Brazil will increase PrEP uptake, persistence, and adherence compared to standard PrEP care provided in health facilities.

Exclusion: Currently using PrEP; HIV positive test result; Not currently sexually active.

Eligibility Criteria:; Aged 15-24 years; Candidate for HIV prevention; Sexually active; Not currently using PrEP; Willing to discuss oral PrEP; Agree to be randomized to either intervention or standard care arm.

ClinicalTrials.gov NCT06661356